시장보고서
상품코드
1611032

안구 임플란트 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Ocular Implants Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030

발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 160 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

안구 임플란트 시장 성장과 동향:

Grand View Research, Inc.의 최신 보고서에 따르면 세계 안구 임플란트 시장 규모는 2030년까지 220억 9,000만 달러에 달할 것으로 예상됩니다.

2025년부터 2030년까지 연평균 5.8%의 CAGR로 성장할 것으로 예상됩니다. 기술적으로 진보된 제품 개발에 대한 관심이 높아지면서 시장을 견인할 것으로 예상됩니다. 또한 녹내장, 백내장, 노인성 황반변성 등 안과 질환의 발병률 증가는 안구 임플란트 수요를 촉진할 것으로 예상됩니다. 세계녹내장협회에 따르면 2020년에는 약 7,960만 명이 녹내장에 걸릴 것으로 예상됩니다.

많은 국가에서 여러 차례의 봉쇄 조치, 여행 제한 및 전면적인 봉쇄 조치로 인해 세계 경제는 큰 손실을 입었고, 경기 침체기로 접어들었으며, COVID-19의 영향은 의료 시스템 전체에 큰 영향을 미치고 있습니다. 일부 시장에서는 COVID-19 진단 및 치료에 안구 임플란트가 필요해 수요가 크게 증가한 반면, 다른 시장에서는 특히 팬데믹이 절정에 달했을 때 매출이 급감하는 모습을 보였습니다. 이 시장은 후자에 속하며, COVID-19 사태로 인한 부정적인 영향을 목격했습니다. 직원과 환자에게 바이러스가 전염되는 것을 피하기 위해 선택적 수술이 취소되거나 연기되어 2020년 안구 임플란트 판매 감소로 이어졌습니다.

그러나 대부분의 국가에서 제3파 또는 제4파의 유사한 영향을 억제하기 위해 백신과 이전 경험에 기반한 특정 전략을 도입한 것이 시장 성장 회복에 도움이 되고 있습니다. 또한, COVID-19 사태로 인해 바이러스 감염 위험이 높은 혼잡한 장소를 피하기 위해 병원보다 안과 전문 의료기관을 찾는 환자가 증가하면서 전문 클리닉에 대한 수요가 증가하고 있습니다. 또한, 직업 및 교육 시스템과 관련된 새로운 역학은 개인의 전체 스크린 사용 시간을 증가시키고 있으며, 이는 안과 질환 발생률 증가에 기여할 것으로 예상됩니다. 이는 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다.

안구 임플란트 시장 보고서 하이라이트

  • 세계 녹내장 발병률 증가로 인해 녹내장 임플란트 제품 부문이 2024년 시장을 주도했습니다.
  • 녹내장 수술 용도는 2024년에 가장 큰 매출 점유율을 차지했으며, 이러한 추세는 예측 기간 동안 계속될 것으로 예상됩니다.
  • 최종 용도별로는 전 세계적으로 입원 환자 수가 증가함에 따라 병원 부문이 2024년 42.29% 이상의 매출 점유율로 시장을 장악했습니다.
  • 전문 안과 기관의 최종 용도 부문은 원격지에서 안과 의료 서비스에 대한 수요가 증가함에 따라 예측 기간 동안 큰 성장을 보일 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 안구 임플란트 시장 변수, 동향, 범위

  • 시장 계통 전망
    • 상부 시장 전망
    • 관련/부수 시장 전망
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
  • 안구 임플란트 시장 분석 툴
    • 업계 분석 - Porter's Five Forces 분석
    • PESTEL 분석

제4장 안구 임플란트 시장 : 제품 추정·동향 분석

  • 부문 대시보드
  • 안구 임플란트 시장 : 제품 변동 분석
  • 안구 임플란트 시장 : 제품별 전망
  • 시장 규모와 예측과 동향 분석, 2018-2030년
  • 안내 렌즈
  • 각막 임플란트
  • 안와 임플란트
  • 녹내장 임플란트
  • 인공눈
  • 기타

제5장 안구 임플란트 시장 : 용도 추정·동향 분석

  • 부문 대시보드
  • 안구 임플란트 시장 : 용도 변동 분석
  • 안구 임플란트 시장 : 용도별 전망
  • 시장 규모와 예측과 동향 분석, 2018-2030년
  • 녹내장 수술
  • 눈 성형술
  • 약물전달
  • 노인황반변성
  • 미적 목적

제6장 안구 임플란트 시장 : 최종 용도 추정·동향 분석

  • 부문 대시보드
  • 안구 임플란트 시장 : 최종 용도 변동 분석
  • 안구 임플란트 시장 : 최종 용도별 전망
  • 시장 규모와 예측과 동향 분석, 2018-2030년
  • 병원
  • 전문 안과
  • 클리닉

제7장 안구 임플란트 시장 : 지역 추정·동향 분석

  • 지역 대시보드
  • 지역별 안구 임플란트 시장 변동 분석
  • 안구 임플란트 시장 : 제품별, 용도별, 최종 용도별 지역 추정·동향 분석
  • 시장 규모와 예측과 동향 분석, 2018-2030년
  • 북미
    • 미국
    • 캐나다
    • 멕시코
    • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 덴마크
    • 스웨덴
    • 노르웨이
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 한국
    • 호주
    • 태국
  • 라틴아메리카
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트
    • 쿠웨이트

제8장 경쟁 구도

  • 시장 진출 기업 분류
  • 주요 기업 개요
    • Alcon, Inc.
    • Bausch + Lomb.
    • Carl Zeiss AG
    • Johnson & Johnson Services, Inc.
    • STAAR SURGICAL
    • MORCHER GmbH
    • Glaukos Corporation.
ksm 24.12.30

Ocular Implants Market Growth & Trends:

The global ocular implants market size is expected to reach USD 22.09 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.8% from 2025 to 2030. Increasing focus on the development of technologically advanced products is expected to drive the market. Additionally, the growing incidence of eye disorders such as glaucoma, cataract, and age-related macular degeneration is predicted to propel the demand for ocular implants. According to the World Glaucoma Association, an estimated 79.6 million individuals were anticipated to have glaucoma in 2020.

Due to the imposition of multiple lockdown restrictions, travel restrictions, and complete lockdowns in many countries, the economies worldwide have observed a major loss moving it into a state of recession. The COVID-19 impact was also strongly felt across the healthcare systems. While certain markets witnessed a major rise in demand due to the need for ocular implants in diagnoses and the treatment of COVID-19, certain other products observed a sharp fall in sales, especially during the peak of the pandemic. The market belonged to the latter and witnessed a negative impact due to the outbreak of COVID-19. The cancellation and postponement of elective surgeries in order to avoid the transmission of the virus to the staff and patients led to a fall in the sales of ocular implants in 2020.

However, the introduction of vaccines and specific strategies based on earlier experience to curtail the similar impact of the third or fourth wave in most countries is helping the market to regain its growth. Additionally, the outbreak of COVID-19 has created a higher preference among patients to visit specialty eye institutes rather than hospitals in order to avoid crowded places that pose a higher threat of contracting the virus, thereby increasing the demand for specialty clinics. Moreover, the new dynamics involved in the occupation and education system have increased the overall screen-time of individuals, which is expected to contribute to the rising incidence of eye diseases. This, in turn, is expected to enhance the market growth during the forecast period.

Ocular Implants Market Report Highlights:

  • The glaucoma implants product segment dominated the market in 2024 owing to the growing incidence of glaucoma globally
  • The glaucoma surgery application held the largest revenue share in 2024 and this trend is expected to continue during the forecast period
  • By end use, the hospitals segment dominated the market with a revenue share of more than 42.29% in 2024 due to the increasing number of hospital admissions across the globe
  • The specialty eye institutes end-use segment is expected to witness significant growth during the forecast period owing to the rising need for eye care services in remote areas

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End-Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End Use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Ocular Implants Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing incidence of eye disorders
      • 3.2.1.2. Growing geriatric and diabetic population
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Recent product recalls
  • 3.3. Ocular Implants Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Ocular Implants Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Ocular Implants Market: Product Movement Analysis
  • 4.3. Ocular Implants Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Intraocular Lens
    • 4.5.1. Intraocular Lens Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Corneal Implants
    • 4.6.1. Corneal Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Orbital Implants
    • 4.7.1. Orbital Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Glaucoma Implants
    • 4.8.1. Glaucoma Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Ocular Prosthesis
    • 4.9.1. Ocular Prosthesis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Ocular Implants Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Ocular Implants Market: Application Movement Analysis
  • 5.3. Ocular Implants Market by Application Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Glaucoma Surgery
    • 5.5.1. Glaucoma Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Oculoplasty
    • 5.6.1. Oculoplasty Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Drug Delivery
    • 5.7.1. Drug Delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Age related Macular Degeneration
    • 5.8.1. Age related Macular Degeneration Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Aesthetic Purpose
    • 5.9.1. Aesthetic Purpose Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Ocular Implants Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Ocular Implants Market: End Use Movement Analysis
  • 6.3. Ocular Implants Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Hospitals
    • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Specialty Eye institutes
    • 6.6.1. Specialty Eye Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Clinics
    • 6.7.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Ocular Implants Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Ocular Implants Market movement analysis
  • 7.3. Ocular Implants Market: Regional Estimates & Trend Analysis by Product, Application & End-use
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. North America
    • 7.5.1. North America Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Europe
    • 7.5.6. Europe Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. UK
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. UK Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Germany
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement scenario
      • 7.5.8.5. Germany Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. France
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement scenario
      • 7.5.9.5. France Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.10. Italy
      • 7.5.10.1. Key Country Dynamics
      • 7.5.10.2. Competitive Scenario
      • 7.5.10.3. Regulatory Framework
      • 7.5.10.4. Reimbursement scenario
      • 7.5.10.5. Italy Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.11. Spain
      • 7.5.11.1. Key Country Dynamics
      • 7.5.11.2. Competitive Scenario
      • 7.5.11.3. Regulatory Framework
      • 7.5.11.4. Reimbursement scenario
      • 7.5.11.5. Spain Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.12. Denmark
      • 7.5.12.1. Key Country Dynamics
      • 7.5.12.2. Competitive Scenario
      • 7.5.12.3. Regulatory Framework
      • 7.5.12.4. Reimbursement scenario
      • 7.5.12.5. Denmark Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.13. Sweden
      • 7.5.13.1. Key Country Dynamics
      • 7.5.13.2. Competitive Scenario
      • 7.5.13.3. Regulatory Framework
      • 7.5.13.4. Reimbursement scenario
      • 7.5.13.5. Sweden Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.14. Norway
      • 7.5.14.1. Key Country Dynamics
      • 7.5.14.2. Competitive Scenario
      • 7.5.14.3. Regulatory Framework
      • 7.5.14.4. Reimbursement scenario
      • 7.5.14.5. Norway Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Japan Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. China Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. India Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. South Korea Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Australia Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Thailand Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Brazil Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Argentina Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. South Africa Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Saudi Arabia Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. UAE Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. Kuwait Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Alcon, Inc.
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Bausch + Lomb.
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Carl Zeiss AG
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Johnson & Johnson Services, Inc.
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. STAAR SURGICAL
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. MORCHER GmbH
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Glaukos Corporation.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제